(BNTX), Pfizer, Inc. (NYSE: PFE) – AstraZeneca, Pfizer / BioNtech Single Shot COVID-19 Jab 80% effective in preventing hospitalizations in the elderly

A recent study found that a dose of either Pfizer Inc (NYSE: PFE) /BioNtech SE (NASDAQ: BNTX) or Oxford-AstraZeneca Plc (NASDAQ: AZN) The COVID-19 vaccine is over 80% effective in reducing infections and serious illnesses in people over the age of 80, Reuters reports.

• Public Health England (PHE) found that the Pfizer jab offered between 57% and 61% protection against disease after the first dose. The AstraZeneca vaccine offered protection between 60% and 73% four weeks after the first injection.
• “These results may also help explain why the number of COVID admissions to intensive care units among people over 80 in the UK has fallen to single figures in the past two weeks,” said UK Health Minister Matt Hancock at a press conference. “It’s really encouraging.”
• PHE has submitted its analysis to peer review after providing initial conclusions of the true impact of the deployment a week ago.
• According to a separate study of healthcare workers, one dose of a vaccine can reduce the number of people getting asymptomatic COVID-19 by 70%.
• The health authority said evidence suggested the Pfizer vaccine resulted in an 83% reduction in deaths from COVID-19 in those over 80. There was no equivalent data for the AstraZeneca vaccine, which started to be administered later.
• Price action: AZN shares are up 0.4% to $ 48.3, BNTX is down 0.3% to $ 108.89 and PFE is down 0.1% to $ 33.65 in the negotiation before marketing during the last check on Tuesday.